Syndax Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352.

CEO

Michael A. Metzger

CEOMichael A. Metzger

Employees

184

Employees184

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2005

Founded2005

Employees

184

Employees184

SNDX Key Statistics

Market cap

1.79B

Market cap1.79B

Price-Earnings ratio

-7.10

Price-Earnings ratio-7.10

Dividend yield

—

Dividend yield—

Average volume

901.04K

Average volume901.04K

High today

$21.24

High today$21.24

Low today

$20.48

Low today$20.48

Open price

$20.59

Open price$20.59

Volume

678.98K

Volume678.98K

52 Week high

$25.34

52 Week high$25.34

52 Week low

$11.22

52 Week low$11.22

SNDX News

Investor's Business Daily 5d

Syndax Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold - Investor's Business Daily

When building your watch list, focus on stocks with an 80 or higher RS Rating. Syndax Pharmaceuticals (SNDX) is one stock that just reached the mark, now earnin...

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell